To print: Select File and then Print from your browser's menu
---------------------------------------------------------------------------------------
Title: Some Antidepressants Associated With Gastrointestinal Bleeding
URL: http://www.pslgroup.com/dg/22530A.htm
Doctor's Guide
July 7, 2008

CHICAGO -- July 7, 2008 -- Selective serotonin reuptake inhibitors (SSRIs) appear to be associated with bleeding in the upper gastrointestinal tract, according to a report in the July issue of Archives of General Psychiatry.

The effects appear increased when antidepressants are combined with other stomach-harming medications and decreased when acid-suppressing agents are used.

"The wide use of this drug class requires research to provide more accurate risk estimates, to identify factors that may further increase the risk and, in particular, to determine whether using acid-suppressing agents may reduce the risk," the authors wrote.

"It is also important to determine whether venlafaxine hydrochloride, a new antidepressant related to SSRIs, also increases the risk of bleeding, as some individual case reports have suggested."

Francisco J. de Abajo, MD, Spanish Agency for Medicines and Healthcare Products, and Luis A. García-Rodríguez, MD, Spanish Centre for Pharmacoepidemiologic Research, Madrid, Spain, studied 1,321 patients who had been referred to a specialist or hospitalised for upper GI bleeding between 2001 and 2005. These cases were compared with 10,000 control subjects who were the same age and sex but did not have upper GI bleeding.

Individuals with upper GI bleeding were significantly more likely than controls to be taking SSRIs (5.3% vs 3.0%) or venlafaxine (1.1% vs 0.3%). The risk of bleeding appeared to be increased further among those taking both SSRIs and other drugs known to be harmful to the GI tract, including nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Acid-suppressing agents, however, were associated with a reduced risk of upper GI bleeding in those taking SSRIs or venlafaxine.

The researchers estimate that in patients not taking acid-suppressing agents, 1 individual per year would develop upper GI tract bleeding for every 2,000 patients taking these antidepressants.

"When both SRIs [SSRIs and venlafaxine] and NSAIDs are concomitantly used, it would be sufficient to treat 250 patients per year for 1 case of upper GI tract bleeding to be attributed to such combination, and 500 patients per year if SRIs are concomitantly used with antiplatelet drugs," the authors wrote.


SOURCE: Archives of General Psychiatry

---------------------------------------------------------------------------------------------
Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.
---------------------------------------------------------------------------------------------
This news story was printed from *Doctor's Guide to the Internet*
located at http://www.docguide.com
---------------------------------------------------------------------------------------

Return to News Story Page

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.
All contents Copyright (c) 1998 P\S\L Consulting Group Inc.
All rights reserved.